Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
75.5M
-
Shares change
-
+764K
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
+$7.26M
-
Put/Call ratio
-
0.52
-
Number of buys
-
85
-
Number of sells
-
-83
-
Price
-
$19.79
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2021
214 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q2 2021.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.5M shares
of 119M outstanding shares and own 63.28% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11.7M shares), FMR LLC (8.49M shares), VANGUARD GROUP INC (4.73M shares), STATE STREET CORP (4.25M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3.1M shares), Farallon Capital Management LLC (2.88M shares), WASATCH ADVISORS INC (2.59M shares), Polar Capital Holdings Plc (2.43M shares), BOXER CAPITAL, LLC (2.1M shares), and RTW INVESTMENTS, LP (2M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.